BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans

被引:121
作者
Boulton, SJ [1 ]
Martin, JS
Polanowska, J
Hill, DE
Gartner, A
Vidal, M
机构
[1] London Res Inst, Canc Res UK, Clare Hall Labs, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
[4] Max Planck Inst Biochem, D-82152 Martinsried, Germany
关键词
D O I
10.1016/j.cub.2003.11.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inherited germline mutations in the tumor suppressor gene BRCA1 predispose individuals to early onset breast and ovarian cancer [1]. BRCA1 together with its structurally related partner BARD1 is required for homologous recombination and DNA double-strand break repair, but how they perform these functions remains elusive [2, 3]. As part of a comprehensive search for DNA repair genes in C. elegans, we identified a BARD1 ortholog. In protein interaction screens, Ce-BRD-1 was found to interact with components of the sumoylation pathway, the TACC domain protein TAC-1, and most importantly, a homolog of mammalian BRCA1. We show that animals depleted for either Ce-brc-1 or Ce-brd-1 display similar abnormalities, including a high incidence of males, elevated levels of p53-dependent germ cell death before and after irradiation, and impaired progeny survival and chromosome fragmentation after irradiation. Furthermore, depletion of ubc-9 and tac-1 leads to radiation sensitivity and a high incidence of males, respectively, potentially linking these genes to the C. elegans BRCA1 pathway. Our findings support a shared role for Ce-BRC-1 and Ce-BRD-1 in C. elegans DNA repair processes, and this role will permit studies of the BRCA1 pathway in an organism amenable to rapid genetic and biochemical analysis.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 34 条
[1]   C-elegans RAD-5/CLK-2 defines a new DNA damage checkpoint protein [J].
Ahmed, S ;
Alpi, A ;
Hengartner, MO ;
Gartner, A .
CURRENT BIOLOGY, 2001, 11 (24) :1934-1944
[2]   The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity [J].
Baer, R ;
Ludwig, T .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (01) :86-91
[3]   Combined functional genomic maps of the C-elegans DNA damage response [J].
Boulton, SJ ;
Gartner, A ;
Reboul, J ;
Vaglio, P ;
Dyson, N ;
Hill, DE ;
Vidal, M .
SCIENCE, 2002, 295 (5552) :127-131
[4]  
BRENNER S, 1974, GENETICS, V77, P71
[5]   Structure of a BRCA1-BARD1 heterodimeric RING-RING complex [J].
Brzovic, PS ;
Rajagopal, P ;
Hoyt, DW ;
King, MC ;
Klevit, RE .
NATURE STRUCTURAL BIOLOGY, 2001, 8 (10) :833-837
[6]   Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase [J].
Chen, A ;
Kleiman, FE ;
Manley, JL ;
Ouchi, T ;
Pan, ZQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :22085-22092
[7]   AZU-1:: A candidate breast tumor suppressor and biomarker for tumor progression [J].
Chen, HM ;
Schmeichel, KL ;
Mian, IS ;
Lelièvre, S ;
Petersen, OW ;
Bissell, MJ .
MOLECULAR BIOLOGY OF THE CELL, 2000, 11 (04) :1357-1367
[8]   Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells [J].
Chen, JJ ;
Silver, DP ;
Walpita, D ;
Cantor, SB ;
Gazdar, AF ;
Tomlinson, G ;
Couch, FJ ;
Weber, BL ;
Ashley, T ;
Livingston, DM ;
Scully, R .
MOLECULAR CELL, 1998, 2 (03) :317-328
[9]  
Chen YM, 1999, J CELL PHYSIOL, V181, P385, DOI 10.1002/(SICI)1097-4652(199912)181:3<385::AID-JCP2>3.0.CO
[10]  
2-4